CDT Equity Inc.

CDT

$0.68

-8.81%

2026-09-04 12:46:45 EDT-$0.07

Healthcare

Biotechnology

NASDAQ

Active Trading

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase ...

Insider Transactions of CDT

Acquisitions (A)

Since Apr 27, 2026

Disposals (D)

Since Apr 27, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Common Stock	A	5,436,830	$0.00
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Common Stock	D	290	$0.00
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Pre-Funded Warrants	D	5,436,830	$0.00
Jul 30, 2026	Regan Andrew	director, officer: Chief Executive Officer	Pre-Funded Warrants	A	5,436,830	$0.00
Jun 18, 2026	Taylor Mark Andrew	10 percent owner	Common Stock	D	5,000	$0.71

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

10,973,660

Total Shares Sold

7,505,120

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Regan Andrew

director, officer: Chief Executive Officer • 5 txns

Taylor Mark Andrew

10 percent owner • 4 txns

Olsen Ulrik K

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Common Stock	A	5,436,830	$0.00	$543.68
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Common Stock	D	290	$0.00	$0.03
Aug 28, 2026	Regan Andrew	director, officer: Chief Executive Officer	Pre-Funded Warrants	D	5,436,830	$0.00	$543.68
Jul 30, 2026	Regan Andrew	director, officer: Chief Executive Officer	Pre-Funded Warrants	A	5,436,830	$0.00	$543.68
Jun 18, 2026	Taylor Mark Andrew	10 percent owner	Common Stock	D	5,000	$0.71	$3,526.00
Jun 18, 2026	Taylor Mark Andrew	10 percent owner	Common Stock	D	5,000	$0.75	$3,755.00
Jun 18, 2026	Taylor Mark Andrew	10 percent owner	Common Stock	D	1,464,711	$1.44	$2,109,183.84
Jun 18, 2026	Taylor Mark Andrew	10 percent owner	Common Stock	D	593,289	$1.40	$829,121.38
May 13, 2026	Regan Andrew	director, officer: Chief Executive Officer	Common Stock	A	100,000	$1.90	$190,000.00
Apr 27, 2026	Olsen Ulrik K	director	Common Stock	—	0	—	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer